ARCHIVES

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

DOD Names Innovator Award Recipients.

April 26, 2002

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003

NCI Toughens Criteria for MERIT Awards

February 23, 1996

Community Oncology Alliance Attack On Republican Leadership Prompts Others To Declare: We Aren’t COA.

September 29, 2006

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993

Dexamethasone Improved Survival Of Leukemia

November 26, 2004